Ann Arbor-based Rubicon Genomics Inc. said its ThruPlex-FD prep kits contributed to the success of a study published in Nature that showed that genomic data extracted from the plasma of cancer patients can be used to track drug resistance and potentially guide treatment.
Mark England was diagnosed with Lymphoma cancer earlier this year and says he understands what people face when fighting the disease.
With a single tap on a smartphone, cancer patients now can access detailed information about treatment options by cancer type, GPS mapping to appointment locations, as well as schedule appointments and connect to their electronic medical record.
Radiation to the chest can damage the heart’s valves and the protective sac around the heart.
The fatigue experienced by patients undergoing cancer treatments has long been recognized by health care providers, although its causes and ways to manage it are still largely unknown.
Two recent studies by Van Andel Research Institute scientists are providing a foundation for a more complete understanding of distinct kidney cancer subtypes, which could pave the way for better treatments.
Lawmakers in Lansing Tuesday will debate whether insurance companies should cover oral cancer treatment drugs.
Kettering University still has plenty of automotive heritage, and boy, does it have a lot of other cool research going, as I learned Friday morning on the final tour stop of the Great Lakes IT Report Fall Tech Tour for 2011.
Intervention Insights, a Grand Rapids-based health care IT company that helps community oncologists develop individualized patient treatment plans, today announced the close of $7.2 million in Series B financing.
Scientists at the Barbara Ann Karmanos Cancer Institute in Detroit today presented data at the American Association for Cancer Research’s 102nd Annual Meeting 2011 showing that when tumor cryoablation — or the freezing of tumor tissue while preserving tumor-associated antigens — is coupled with immune system modulation, the procedures have the potential to initiate or amplify tumor immunity.